Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD)
Conditions
Interventions
None listed
Sponsors
Japan Agency for Medical Research and Development (AMED)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. ASD and ADHD patients diagnosed by specialists based on DSM-5. Typically developed healthy subjects who agree to participate in this study. 2. Subjects who did not have any serious neuropsychiatric disorders, except for neurodevelopmental disorders, and severe physical illness. 3. Subjects who can understand this study and give written informed consent. A subject under the age of 20 needs informed consent from a legal representative. 4. Age more than 15 years old.
Exclusion criteria
Exclusion criteria: 1. Subjects who are regarded inappropriate as a participant by attending psychiatrists. 2. Subjects who fall into the followings; cardiac pacemaker, cerebral artery clip, Implanted medical devices (ICD, cochlear implant, nerve stimulator, other), implanted infusion pump, embedded metal in the body, pregnancy or possibly pregnant, tattoos, permanent makeup and so on. These potential risks for MRI scan are screened by Medical Questionnaire for MRI Scan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MRI data (fMRI, resting-state fMRI, structural MRI, and DTI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical and Cognitive data | — |
Countries
Japan
Contacts
Public ContactNakamura Motoaki
Showa University Medical Institute of Developmental Disabilities Research
Outcome results
None listed